128 related articles for article (PubMed ID: 11100068)
1. Sarcomatoid renal cell carcinoma of papillary origin. A case report and cytogenic evaluation.
Cohen RJ; McNeal JE; Susman M; Sellner LN; Iacopetta BJ; Weinstein SL; Dawkins HJ
Arch Pathol Lab Med; 2000 Dec; 124(12):1830-2. PubMed ID: 11100068
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
3. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Malouf GG; Ali SM; Wang K; Balasubramanian S; Ross JS; Miller VA; Stephens PJ; Khayat D; Pal SK; Su X; Sircar K; Tamboli P; Jonasch E; Tannir NM; Wood CG; Karam JA
Eur Urol; 2016 Aug; 70(2):348-57. PubMed ID: 26895810
[TBL] [Abstract][Full Text] [Related]
4. Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization.
Salama ME; Worsham MJ; DePeralta-Venturina M
Arch Pathol Lab Med; 2003 Sep; 127(9):1176-81. PubMed ID: 12946227
[TBL] [Abstract][Full Text] [Related]
5. Sarcomatoid renal cell carcinoma.
Akhtar K; Shamshad A; Sufian Z; Tariq M
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):120-2. PubMed ID: 21196626
[TBL] [Abstract][Full Text] [Related]
6. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
[TBL] [Abstract][Full Text] [Related]
7. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma.
Cossu-Rocca P; Eble JN; Delahunt B; Zhang S; Martignoni G; Brunelli M; Cheng L
Mod Pathol; 2006 Apr; 19(4):488-93. PubMed ID: 16554730
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study.
Mai KT; Faraji H; Desantis D; Robertson SJ; Belanger EC; Levac J
Virchows Arch; 2010 Jan; 456(1):77-84. PubMed ID: 20033232
[TBL] [Abstract][Full Text] [Related]
9. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
10. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991
[TBL] [Abstract][Full Text] [Related]
11. Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity.
Sanfrancesco JM; Eble JN; Grignon DJ; Wang M; Zhang S; Sundaram CP; Idrees MT; Pili R; Kouba E; Cheng L
Mol Carcinog; 2017 Nov; 56(11):2527-2537. PubMed ID: 28667776
[TBL] [Abstract][Full Text] [Related]
12. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
[TBL] [Abstract][Full Text] [Related]
13. Multifocal renal cancer: genetic basis and its medical relevance.
Bottaro DP; Linehan WM
Clin Cancer Res; 2005 Oct; 11(20):7206-8. PubMed ID: 16243789
[No Abstract] [Full Text] [Related]
14. Application of molecular cytogenetic techniques to the evaluation of renal parenchymal tumors.
Kovacs G
J Cancer Res Clin Oncol; 1990; 116(4):318-23. PubMed ID: 2202729
[TBL] [Abstract][Full Text] [Related]
15. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study.
Hughson MD; Johnson LD; Silva FG; Kovacs G
Mod Pathol; 1993 Jul; 6(4):449-56. PubMed ID: 8415591
[TBL] [Abstract][Full Text] [Related]
16. A novel oncocytoid papillary renal cell carcinoma, type 2, with aberrant cytogenetic abnormalities.
Sinniah R; Teo A; Murch A
Pathology; 2013 Jan; 45(1):86-8. PubMed ID: 23255034
[No Abstract] [Full Text] [Related]
17. Solid variant of papillary renal cell carcinoma with spindle cell and tubular components.
Cantley R; Gattuso P; Cimbaluk D
Arch Pathol Lab Med; 2010 Aug; 134(8):1210-4. PubMed ID: 20670145
[TBL] [Abstract][Full Text] [Related]
18. Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype.
Meloni AM; Dobbs RM; Pontes JE; Sandberg AA
Cancer Genet Cytogenet; 1993 Jan; 65(1):1-6. PubMed ID: 8431910
[TBL] [Abstract][Full Text] [Related]
19. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
20. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization.
Hughson MD; Dickman K; Bigler SA; Meloni AM; Sandberg AA
Cancer Genet Cytogenet; 1998 Oct; 106(2):93-104. PubMed ID: 9797772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
